When clinicians don’t have timely diagnostic information, unnecessary antibiotic use becomes more likely. That’s why improving stewardship requires more than innovation. It requires faster answers and workflows that support action.
In a recent article, Dr. Ephraim Tsalik highlights the critical role diagnostics play in helping clinicians make informed treatment decisions when time matters most.
At PHASE Scientific Americas, we’re focused on supporting those decisions at the point of care. Tools like FebriDx® help differentiate bacterial acute respiratory infection from non-bacterial etiology after 10 minutes, helping clinicians make more informed treatment decisions and support responsible antibiotic use.
Because addressing AMR won’t come from a single breakthrough. It will come from millions of better decisions, made every day.
